Scientists hunt blood clues to predict leukemia treatment success
NCT ID NCT07250217
Summary
This study aims to identify specific markers in the blood and bone marrow of elderly patients with acute myeloid leukemia (AML). Researchers will collect samples from 30 participants to see if certain patterns can predict how well patients respond to the drug azacitidine. The goal is to better understand which patients are likely to benefit from this treatment.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ACUTE MYELOBLASTIC LEUKEMIA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
GHRMSA
RECRUITINGMulhouse, 68100, France
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
-
Groupe Hospitalier de la Région de Mulhouse et Sud Alsace
RECRUITINGMulhouse, Alsace, 68100, France
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
Conditions
Explore the condition pages connected to this study.